U.S. Medical Equipment Stock News

Recent analyst revisions to earnings estimates for Skyward Specialty Insurance Group (SKWD) have drawn fresh attention to the stock, with sentiment also supported by favorable momentum rankings and reports of continued market share gains. See our latest analysis for Skyward Specialty Insurance Group. At a share price of $47.39, Skyward Specialty Insurance Group has seen a 7 day share price return of 7.63%, while its 1 year total shareholder return has declined 23.44%. However, the 3 year...

Newell Brands (NasdaqGS:NWL) is launching a limited edition Sharpie and Elmer's collection tied to Disney and Pixar's upcoming Toy Story 5. The range features Toy Story characters and themed designs and is expected to appear across major retailers such as Amazon, Walmart, and Target. The collaboration targets both children and adults, aiming to connect with fans of the franchise ahead of the film's release. For Newell Brands, best known in this context for its Sharpie and Elmer's lines,...

Solventum overview and recent performance Solventum (SOLV) has drawn fresh attention as a standalone healthcare company, with investors weighing its recent trading performance against fundamentals such as revenue of US$8.26b and net income of US$1.43b. See our latest analysis for Solventum. At a share price of US$76.13, Solventum has delivered a 1-month share price return of 8.7% and a 1-year total shareholder return of 4.63%, suggesting recent momentum has improved after weaker year to date...

Without a specific news trigger, eToro Group (NasdaqGS:ETOR) is drawing attention for its recent share performance, with the stock up 1.7% over the past month and 27.7% over the past 3 months. See our latest analysis for eToro Group. That short term momentum, with a 1 month share price return of 1.7% and a 3 month share price return of 27.7%, sits against a very weak 1 year total shareholder return, which is down 39.6%. If you are comparing eToro Group with other opportunities in similar...

In May 2026, Novanta Inc. reported first-quarter sales of US$257.71 million with essentially flat net income year over year, issued second-quarter and full-year 2026 revenue guidance of US$259 million to US$264 million and US$1.04 billion to US$1.06 billion respectively, and reiterated acquisitions and manufacturing optimization as core priorities. Management also highlighted record bookings, strong momentum in Robotics & Automation and Advanced Surgery, and a disciplined acquisition...

Wondering if American Electric Power Company at US$128.87 is offering fair value today, or if the price is running ahead of itself? This article focuses squarely on what the numbers say about the stock. The stock is up 0.7% over the past week and 11.3% year to date, while the 1 year and 5 year returns sit at 29.2% and 80.0%. These figures can influence how the market is thinking about both upside and risk. Recent news coverage has centered on American Electric Power Company as a large...

Amgen announced that long-serving CFO Peter Griffith will retire from his role. Thomas Dittrich has been appointed as incoming CFO, with the transition marking a key governance change. For investors watching Amgen, ticker NasdaqGS:AMGN, this leadership shift arrives with the stock trading around $331.57 and showing multi year gains, including 25.9% over the past year and 64.3% over three years. These figures frame the CFO transition as a governance development at a company that has...

Ubiquiti Inc. recently reported third-quarter 2026 results showing higher sales of US$788.2 million and net income of US$233.91 million compared with the same period a year earlier, alongside improved earnings per share on both a basic and diluted basis. Following these earnings, the company affirmed a quarterly cash dividend of US$0.80 per share, payable on May 26, 2026, with both the ex-dividend and record dates set for May 18, 2026, underscoring its ongoing capital return policy. We will...

Archer Aviation (NYSE:ACHR) is in an escalating legal dispute with Joby Aviation that centers on allegations of corporate espionage and competitive tactics. At the same time, Archer has agreed to acquire Hawthorne Municipal Airport in a transaction reported to be over $100 million, aiming to build out urban air mobility operations ahead of the 2028 Los Angeles Olympics. Archer Aviation enters this period of legal and operational tension with the stock at $5.78 and a value score of 4, after...

MSC Industrial Direct (MSM) has drawn fresh attention after recent share price moves, with the stock up 9.3% over the past month and 13.1% over the past 3 months, putting recent performance in focus for investors. See our latest analysis for MSC Industrial Direct. At a share price of $106.17, MSC Industrial Direct’s 30 day share price return of 9.3% and year to date share price return of 23.7% sit alongside a 1 year total shareholder return of 39.8%. These figures point to solid momentum...

DENTSPLY SIRONA (XRAY) stock has drawn attention after a period of weak share performance, with the price around $9.84 and total returns down over the past year and over the past 3 months. See our latest analysis for DENTSPLY SIRONA. The recent 1-day share price return of 1.03% sits against a 30-day share price return that is down 23.06% and a 1-year total shareholder return that is down 35.47%, suggesting momentum has been fading rather than building. If this kind of volatility has you...

Wondering if IQVIA Holdings at around US$171.50 is offering value right now, or if you are paying up for growth expectations that may already be in the price. The stock is roughly flat over the past week, down around 3% over the past month and down 23.9% year to date, yet it is still up 24.9% over the past year. This can leave investors questioning whether the recent weakness signals changing risk sentiment or just normal volatility. Recent headlines have focused on IQVIA Holdings' role in...

Wondering whether Littelfuse at around US$441 per share still offers value or if the easy gains are behind it? This article walks through what the current price may say about expectations baked into the stock. The share price has been through a sharp pullback of about 8.3% over the past week, after a strong 11.8% move over the last month and sizeable returns of 68.1% year to date and 111.9% over the past year. Recent headlines around Littelfuse have focused on its positioning within the...

What triggered fresh interest in Nordic American Tankers? Recent analyst upgrades on Nordic American Tankers (NAT) followed sharply higher full year earnings estimates, while newly secured vessel contracts at premium day rates highlighted demand for its Suezmax crude fleet. See our latest analysis for Nordic American Tankers. At a share price of US$5.60, Nordic American Tankers has seen its 90 day share price return of 15.94% and year to date share price return of 66.17%. The 1 year total...

Investors may be wondering whether Black Stone Minerals, at around US$13.93, is offering good value right now or if most of the potential upside is already reflected in the price. The stock has returned 2.8% over the past week, 1.2% over the past month, 3.1% year to date and 12.9% over the last year. This naturally raises questions about how much risk and reward are currently embedded in the price. Recent coverage has focused on Black Stone Minerals as an income-oriented US energy stock and...

If you are wondering whether Omnicell's current share price still reflects good value or if most of the opportunity is already priced in, the starting point is understanding how its valuation stacks up across several methods. Over the past year, the stock is up 63.6%, with a 3.6% gain over the last week and 18.3% over the past month, even though the year to date return is slightly down at 0.9% and longer term 3 year and 5 year returns are lower at 38.8% and 67.7% respectively. These price...

Structure Therapeutics (GPCR) drew fresh attention after reporting first quarter results for the period ended March 31, 2026, with a net loss of US$75.97 million compared with US$46.83 million a year earlier. See our latest analysis for Structure Therapeutics. The first quarter update and wider clinical pipeline work have come against a backdrop of a share price that is down 23.5% over the past month and 45.9% year to date, while the 1 year total shareholder return of 52.7% and 3 year total...

IDEAYA Biosciences (IDYA) is back in focus after reporting OptimUM-02 data showing longer median progression-free survival for its lead melanoma drug, darovasertib, and signaling plans for an NDA filing and broader pipeline expansion. See our latest analysis for IDEAYA Biosciences. IDEAYA's recent darovasertib update comes after a choppy few months, with the share price up 4.7% over the last day and 2.6% over the past week, but down around 12% year to date. The 1 year total shareholder return...

ICL Group (NYSE:ICL) is expanding in China with a new food specialty plant, targeting higher value ingredients for the local market. The company has also entered a major distribution agreement in China to widen access to its specialty products. At the same time, ICL is growing its specialty fertilizers business in North America, adding another leg to its international buildout. ICL Group operates across specialty minerals, advanced fertilizers and food ingredients, so these moves align...

In the last week, the United States market has stayed flat, yet it is up 27% over the past year with earnings expected to grow by 17% per annum in the coming years. In this context, identifying stocks that may be undervalued by the market involves looking for companies whose intrinsic value might not be fully reflected in their current share prices despite these positive growth trends.

The market remained flat over the last week but has shown a robust 27% increase over the past year, with earnings projected to grow by 17% annually. In this context, identifying growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business and have shown impressive revenue growth.

The market remained flat over the last week, but it has risen 27% in the past 12 months, with earnings forecasted to grow by 17% annually. Though the term 'penny stock' might sound like a relic of past trading days, these smaller or newer companies can still offer significant opportunities when built on solid financials. We've selected three examples of penny stocks that combine balance sheet strength with potential for outsized gains, providing investors a chance to uncover hidden value in...

Over the last 7 days, the United States market has remained flat, yet it has seen a remarkable increase of 27% over the past year with earnings forecasted to grow by 17% annually. In such a dynamic environment, identifying stocks that are not only resilient but also poised for growth can uncover hidden opportunities in an investor's portfolio.

Earlier this month, LeMaitre Vascular reported quarterly revenues of US$66.55 million, an 11.2% year-on-year increase, alongside an earnings beat versus analyst expectations, but paired this with comparatively weaker full-year guidance than its peer group. Management is also actively engaging investors through recent and upcoming appearances at major healthcare conferences hosted by Bank of America, Jefferies, and Goldman Sachs, signaling a focus on explaining the company’s outlook and...